Diabetes Core Update: Influenza and Diabetes Part 2– September 2020

In this second episode of the three-part series “Influenza and Diabetes,” Drs. John Russell and Neil Skolnik discuss the consequences of influenza for persons with diabetes, the specific benefits of influenza vaccination in persons with diabetes –  including new information on the cardiovascular benefits of influenza vaccination in diabetes –  and discuss the details of […]

Continue Reading

6.

Very Light, No Sugar celebrated its sixth anniversary this September. Every year I am humbled to remember that this website has been read by people in more than 100 countries worldwide. Other aspects of life have taken up more of my time and energy in recent years, and I have certainly reduced my blogging frequency. […]

Continue Reading

New technique efficiently converts human stem cells into insulin-producing cells

Researchers have converted human stem cells into insulin-producing cells and demonstrated in mice infused with such cells that blood sugar levels can be controlled and diabetes functionally cured for nine months. The findings, from researchers at Washington University School of Medicine in St. Louis, are published online Feb. 24 in the journal Nature Biotechnology. “These […]

Continue Reading

Telemedicine Study

Doximity Study Finds Telemedicine Will Account for $29 Billion in Healthcare Services in 2020  Researchers Also Estimate that 20% of All Medical Office Visits Will Be Virtual this Year SAN FRANCISCO, Calif. – September 16, 2020– Doximity, the professional medical network, today published its “2020 State of Telemedicine Report,” a comprehensive analysis of telehealth trends […]

Continue Reading

Diabetes Core Update: SGLT-2 inhibitors – Cardiovascular Effects– Sept. 2020

In this first episode of a three-part series on SGLT-2 inhibitors Drs. John Russell and Neil Skolnik discuss the Cardiovascular Outcome Trials (CVOTs) of the SGLT-2 inhibitors, as well as the place of the SGLT-2is in the American Diabetes Association Guidelines and answer some common practical questions about SGLT-2 inhibitor use.  In episodes 2 and […]

Continue Reading